Page 21 - முதலீட்டாளர் உறவுகள் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
This announcement (the
Announcement ) and the information contained herein are not for release, distribution or publication in whole or in part, directly or indirectly, in or into the United States, Canada, Australia, Japan, South Africa or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. The Offering and the distribution of this Announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This Announcement is not an offer to sell or a solicitation of any offer to buy or subscribe for any securities of the Company in any jurisdiction where such offer, sale or subscription would be unlawful and the Announcement and the information
Apogee Enterprises Inc (APOG) Q4 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
DGAP-Adhoc: OPDEnergy, S.A.: Intention to float on the spanish stock exchanges
OPDEnergy, S.A.: INTENTION TO FLOAT ON THE SPANISH STOCK EXCHANGES
08-Apr-2021 / 08:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
FOR IMMEDIATE RELEASE
OPDENERGY HOLDING, S.A. (
Offering ) of its ordinary shares (the
Shares ) to qualified investors. The Offering will consist of a primary offering of new Shares (the
New Shares ) by the Company expected to raise gross proceeds of approximately €400 million to fund its business plan and a secondary offering by one of the existing shareholders of the Company, which approximately 15.64% of the current share capital, to raise gross proceeds of approximately €17 million.
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland, April 07, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, today announced that in connection with hiring Dr. Hideki Garren as Prothena’s Chief Medical Officer, the compensation committee of the Company’s board of directors granted Dr. Garren, an option to purchase 250,000 ordinary shares of the Company. Such stock option has an exercise price per share equal to $24.90, which was the closing trading price on April 5, 2021, the date of the grant. In addition, in connection with hiring a new employee, the compensation committee of the Company’s board of directors granted the individual an option to purchase 30,000 ordinary shares of the Company. Such stock option has an exercise price per share equa
vimarsana © 2020. All Rights Reserved.